Lipoic Acid for Progressive Multiple Sclerosis (MS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rebecca I. Spain, MD MSPH
VA Portland Health Care System, Portland, OR
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of Colorado
Aurora, Colorado, United States
- Washington Dc Va Medical Center, Washington, Dc
Washington D.C., District of Columbia, United States
- Va Portland Health Care System, Portland, Or
Portland, Oregon, United States
- Va North Texas Health Care System Dallas Va Medical Center, Dallas, Tx
Dallas, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Va Salt Lake City Health Care System, Salt Lake City, Ut
Salt Lake City, Utah, United States
- University of Vermont
Burlington, Vermont, United States
- Swedish Medical Center
Seattle, Washington, United States
- Va Puget Sound Health Care System Seattle Division, Seattle, Wa
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Aug 2018
- Primary completion
- 31 Dec 2023
- Completion
- 30 Jun 2024
- Last update posted
- 3 Mar 2025
- Registered enrollment
- 115
- Registry id
- NCT03161028
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.